<code id='D287CC43DC'></code><style id='D287CC43DC'></style>
    • <acronym id='D287CC43DC'></acronym>
      <center id='D287CC43DC'><center id='D287CC43DC'><tfoot id='D287CC43DC'></tfoot></center><abbr id='D287CC43DC'><dir id='D287CC43DC'><tfoot id='D287CC43DC'></tfoot><noframes id='D287CC43DC'>

    • <optgroup id='D287CC43DC'><strike id='D287CC43DC'><sup id='D287CC43DC'></sup></strike><code id='D287CC43DC'></code></optgroup>
        1. <b id='D287CC43DC'><label id='D287CC43DC'><select id='D287CC43DC'><dt id='D287CC43DC'><span id='D287CC43DC'></span></dt></select></label></b><u id='D287CC43DC'></u>
          <i id='D287CC43DC'><strike id='D287CC43DC'><tt id='D287CC43DC'><pre id='D287CC43DC'></pre></tt></strike></i>

          Home / explore / hotspot

          hotspot


          hotspot

          author:entertainment    Page View:78
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In